PLoS ONE (Jan 2018)

Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses.

  • Christopher W Pohlmeyer,
  • Sarah B Laskey,
  • Sarah E Beck,
  • Daniel C Xu,
  • Adam A Capoferri,
  • Caroline C Garliss,
  • Megan E May,
  • Alison Livingston,
  • Walt Lichmira,
  • Richard D Moore,
  • M Sue Leffell,
  • Nicholas J Butler,
  • Jennifer E Thorne,
  • John A Flynn,
  • Robert F Siliciano,
  • Joel N Blankson

DOI
https://doi.org/10.1371/journal.pone.0192098
Journal volume & issue
Vol. 13, no. 2
p. e0192098

Abstract

Read online

Heterologous immunity is an important aspect of the adaptive immune response. We hypothesized that this process could modulate the HIV-1-specific CD8+ T cell response, which has been shown to play an important role in HIV-1 immunity and control. We found that stimulation of peripheral blood mononuclear cells (PBMCs) from HIV-1-positive subjects with microbial peptides that were cross-reactive with immunodominant HIV-1 epitopes resulted in dramatic expansion of HIV-1-specific CD8+ T cells. Interestingly, the TCR repertoire of HIV-1-specific CD8+ T cells generated by ex vivo stimulation of PBMCs using HIV-1 peptide was different from that of cells stimulated with cross-reactive microbial peptides in some HIV-1-positive subjects. Despite these differences, CD8+ T cells stimulated with either HIV-1 or cross-reactive peptides effectively suppressed HIV-1 replication in autologous CD4+ T cells. These data suggest that exposure to cross-reactive microbial antigens can modulate HIV-1-specific immunity.